Firms unite to develop drugs targeting protein homeostasis

Forma Therapeutics and Celgene will collaborate in the discovery, development and commercialization of drug candidates that can regulate protein homeostasis targets. Forma will get an upfront payment and as much as $200 million in research funding. In exchange, Celgene will get the rights to develop and market several drug candidates outside the U.S. Forma will keep the U.S. rights to the drugs arising from the collaboration.

View Full Article in:

Genetic Engineering & Biotechnology News · BioWorld (free content)

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Paralegal
Mylan Inc.
Washington, DC
Health Care Exchange Account Manager
Kaiser Permanente
San Diego, CA
Director of Actuarial Services, Government Programs
PacificSource
Springfield, OR
Director, Health Plan Claims Operations
Group Health Cooperative
Seattle, WA
Stop Loss Sales Executive
Blue Cross Blue Shield of MA
Boston, MA